Agilent stock slips as coronavirus dings outlook
REPORTER
Agilent Techonologies Inc. A, -1.20% shares declined in the extended session Tuesday after the lab instruments maker said its outlook would be impacted by the novel coronavirus. Agilent shares declined 1% after hours, following a 1.2% decline in the regular session to close at $84.79. Agilent expects earnings of 72 cents to 76 cents a share on revenue of $1.28 billion to $1.32 billion, while analysts had forecast earnings of 79 cents a share on revenue of $1.34 billion, "after factoring in the potential impact of the coronavirus disease 2019 (COVID-19)," the company said in a statement. The company reported fiscal first-quarter net income of $197 million, or 63 cents a share, compared with $504 million, or $1.57 a share, in the year-ago period. Adjusted earnings were 81 cents a share. Revenue rose to $1.36 billion from $1.28 billion in the year-ago quarter. Analysts surveyed by FactSet had forecast earnings of 81 cents a share on revenue of $1.35 billion.